Copyright
©The Author(s) 2023.
World J Gastroenterol. Sep 7, 2023; 29(33): 4975-4990
Published online Sep 7, 2023. doi: 10.3748/wjg.v29.i33.4975
Published online Sep 7, 2023. doi: 10.3748/wjg.v29.i33.4975
Figure 1 Pathological changes in mouse liver tissues after rAAV-Angiotensin-converting enzyme 2 treatment (magnification × 100).
A: Effect of rAAV-ACE2 treatment on liver fibrosis in mice was assessed by Hematoxylin and eosin staining; B: Effect of rAAV-ACE2 treatment on liver fibrosis in mice was assessed by Masson trichrome staining; C: Effect of rAAV-ACE2 treatment on liver fibrosis in mice was assessed by Sirius red staining; D: The quantity of collagen production in each group was analyzed using Image-Pro Plus 6.0. aP < 0.01 vs Control; bP < 0.05 vs CCl4; cP < 0.05 vs rAAV-ACE2 + CCl4. Rapa: Rapamycin; ACE2: Angiotensin-converting enzyme 2.
- Citation: Wu Y, Yin AH, Sun JT, Xu WH, Zhang CQ. Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells. World J Gastroenterol 2023; 29(33): 4975-4990
- URL: https://www.wjgnet.com/1007-9327/full/v29/i33/4975.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i33.4975